Liver Transplantation (LTx) is a rational therapeutic option for selected HIV-infected patients who have concomitant end-stage liver disease (ESLD). In particular, the use of atazanavir (ATV) in the setting of patients with HIV infection suffering from ESLD is actually controindicated.
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation / Cocchi, S.; Guaraldi, Giovanni; Ciaffi, S.; Motta, A.; Pinetti, D.; Codeluppi, M.; Bonora, S.; DI BENEDETTO, Fabrizio; Masetti, M.; Di Sandro, S.; Nardini, Giulia; Zona, S.; Bertolini, A.; Gerunda, Giorgio Enrico; Esposito, Roberto. - STAMPA. - # P4.2/03:(2007), pp. not available-not available. (Intervento presentato al convegno EACS tenutosi a Madrid, Spain nel 24-27 October 2007).
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation
GUARALDI, Giovanni;DI BENEDETTO, Fabrizio;Di Sandro S.;NARDINI, Giulia;GERUNDA, Giorgio Enrico;ESPOSITO, Roberto
2007
Abstract
Liver Transplantation (LTx) is a rational therapeutic option for selected HIV-infected patients who have concomitant end-stage liver disease (ESLD). In particular, the use of atazanavir (ATV) in the setting of patients with HIV infection suffering from ESLD is actually controindicated.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
